Biotech News

Vertex Pharmaceuticals Secures FDA Approval for JOURNAVX, a Non-Opioid Pain Treatment

Leveragen and Moonlight Bio Partner to Develop Next-Generation T Cell Therapies

Helicore Biopharma Launches from Stealth Mode with $65M Series A Round

Atalanta Therapeutics Completes $97M Series B Financing to Advance RNAi Therapies

Commit Biologics Secures €5.5M in Extension to Seed Financing

Lutris Pharma Secures $30 Million to Advance Development of LUT014

Orgenesis Secures $5 Million Equity Investement

Lyndra Therapeutics Welcomes Adam Sayer as President and CEO

miRecule Partners with GBI Biomanufacturing to Advance ARC Therapies

Amgen Inaugurates Cutting-Edge Facility in Holly Springs

Alvotech and Teva Announce U.S. FDA Filing Acceptance of Biologics License Applications for AVT05

Ascentage Pharma Raises $126M in Landmark US Biotech IPO

AbbVie Partners with Neomorph to Advance Oncology and Immunology Treatments

Disc Medicine Raises $225.5M, Eyes Bitopertin Commercialisation

Bioxytran Secures $1.6M Investment from TRITON FUNDS to Drive Clinical Trials

Polyrizon Begins GMP Manufacturing for PL-14 Allergy Blocker Ahead of 2025 Clinical Trial

Belhaven Biopharma Secures $11 Million in Funding for Nasdepi Clinical Program and FDA Preparation

ONGENO Secures €3.5 Million to Advance MS Stem Cell Trials